[HTML][HTML] Plant toxic proteins: their biological activities, mechanism of action and removal strategies

E Kocyigit, B Kocaadam-Bozkurt, O Bozkurt… - Toxins, 2023 - mdpi.com
Plants evolve to synthesize various natural metabolites to protect themselves against
threats, such as insects, predators, microorganisms, and environmental conditions (such as …

[HTML][HTML] Aberrant protein synthesis and cancer development: The role of canonical eukaryotic initiation, elongation and termination factors in tumorigenesis

A Rubio, GD Garland, A Sfakianos, RF Harvey… - Seminars in Cancer …, 2022 - Elsevier
In tumourigenesis, oncogenes or dysregulated tumour suppressor genes alter the canonical
translation machinery leading to a reprogramming of the translatome that, in turn, promotes …

Strategies to mitigate the on-and off-target toxicities of recombinant immunotoxins: an antibody engineering perspective

M Li, S Mei, Y Yang, Y Shen, L Chen - Antibody therapeutics, 2022 - academic.oup.com
Targeted cancer therapies using immunotoxins have achieved remarkable efficacy in
hematological malignancies. However, the clinical development of immunotoxins is also …

Use of exogenous enzymes in human therapy: approved drugs and potential applications

P Cioni, E Gabellieri, B Campanini… - Current Medicinal …, 2022 - ingentaconnect.com
The development of safe and efficacious enzyme-based human therapies has increased
greatly in the last decades, thanks to remarkable advances in the understanding of the …

[HTML][HTML] The ribosome-inactivating proteins MAP30 and Momordin inhibit SARS-CoV-2

NR Watts, E Eren, I Palmer, PL Huang, PL Huang… - Plos One, 2023 - journals.plos.org
The continuing emergence of SARS-CoV-2 variants has highlighted the need to identify
additional points for viral inhibition. Ribosome inactivating proteins (RIPs), such as MAP30 …

Biosynthesized tumor acidity and MMP dual-responsive plant toxin gelonin for robust cancer therapy

GB Ding, H Cao, C Zhu, F Chen, J Ye, BC Li… - Biomaterials …, 2024 - pubs.rsc.org
Among all kinds of anticancer agents, small molecule drugs produce an unsatisfactory
therapeutic effect due to the lack of selectivity, notorious drug resistance and side effects …

[HTML][HTML] A sixty-year research and development of trichosanthin, a ribosome-inactivating protein

JQ Lu, KB Wong, PC Shaw - Toxins, 2022 - mdpi.com
Tian Hua Fen, a herbal powder extract that contains trichosanthin (TCS), was used as an
abortifacient in traditional Chinese medicine. In 1972, TCS was purified to alleviate the side …

Isomorphic fluorescent nucleosides facilitate real‐time monitoring of RNA depurination by ribosome inactivating proteins

D Cong, Y Li, PT Ludford III, Y Tor - Chemistry–A European …, 2022 - Wiley Online Library
Ribosome‐inactivating proteins, a family of highly cytotoxic proteins, interfere with protein
synthesis by depurinating a specific adenosine residue within the conserved α‐sarcin/ricin …

[HTML][HTML] Cytotoxicity effect of quinoin, type 1 ribosome-inactivating protein from quinoa seeds, on glioblastoma cells

R Rotondo, S Ragucci, S Castaldo, MA Oliva, N Landi… - Toxins, 2021 - mdpi.com
Ribosome-inactivating proteins (RIPs) are found in several edible plants and are well
characterized. Many studies highlight their use in cancer therapy, alone or as …

[HTML][HTML] Antibody-based immunotoxins for colorectal cancer therapy

L Sanz, R Ibáñez-Pérez, P Guerrero-Ochoa… - Biomedicines, 2021 - mdpi.com
Monoclonal antibodies (mAbs) are included among the treatment options for advanced
colorectal cancer (CRC). However, while these mAbs effectively target cancer cells, they …